Tickers

1. Composite Trajectory Verdict

For a SaaS-focused software company like AVPT, the income statement (revenue growth, operating leverage, profitability inflection) and cash flow statement (operating cash generation, FCF conversion) carry the most weight; the balance sheet is strong but less dynamic.

Composite Trajectory: Improving

Annual revenue grew 27% to $419.5 million with SaaS revenue up 38% to $319.2 million (10-K 2025-12-31, Consolidated Statements of Operations). GAAP operating income swung from $7.2 million to $33.0 million, and net income turned positive at $35.1 million from a $29.1 million loss (10-K 2025-12-31, Consolidated Statements of Operations). Six-month 2026 operating cash flow jumped to $40.2 million from $20.8 million a year earlier (10-Q 2026-06-30, Consolidated Statements of Cash Flows). The balance sheet shows no debt, cash of $417.3 million at June 30 2026, and equity of $436.9 million (10-Q 2026-06-30, Consolidated Balance Sheets). The only counter‑trend is a modest gross‑margin compression (74.1% → 73.1% in Q2) and a slight annual decline in operating cash flow (2025 vs 2024), but operating leverage and profitability trends dominate.

2. Red Flags

• Operating cash flow declined slightly year‑over‑year despite 27% revenue growth: $85.3 million in FY2025 vs $88.9 million in FY2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Gross margin compression: GAAP gross margin fell from 75.0% (FY2024) to 74.1% (FY2025) and from 74.0% (Q2 2025) to 73.1% (Q2 2026) (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, MD&A Cost of Revenue table).
• Large one‑time tax benefit inflated Q2 2026 net income: A $19.9 million valuation‑allowance release drove a $15.6 million tax benefit, lifting net income to $27.6 million from $2.9 million (10-Q 2026-06-30, MD&A Income Tax Provision).
• Non‑GAAP operating margin declined in Q2 2026: Fell to 16.3% from 18.4% in Q2 2025, attributed to planned investment increases (10-Q 2026-06-30, MD&A Non-GAAP Operating Income table).
• Deferred contract costs rising steadily: Increased from $59.8 million (Dec 2024) to $71.3 million (Dec 2025) to $74.3 million (June 2026), reflecting higher sales‑commission capitalization (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets).
• Revolving credit facility matures November 2026 with no borrowings outstanding but covenant compliance required (10-K 2025-12-31, MD&A Liquidity and Capital Resources; 10-Q 2026-06-30, MD&A Indebtedness).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Annual GAAP operating income rose from $7.2 million (2.2% margin) in FY2024 to $33.0 million (7.9% margin) in FY2025, and net income swung to a $35.1 million profit from a $29.1 million loss (10-K 2025-12-31, Consolidated Statements of Operations). Six-month 2026 GAAP operating income more than doubled to $23.0 million (9.5% margin) from $10.4 million (5.3% margin) in the prior-year period (10-Q 2026-06-30, Consolidated Statements of Operations). Quarterly Q2 2026 GAAP operating income increased to $10.2 million (8.2% margin) from $7.1 million (7.0% margin) (10-Q 2026-06-30, Consolidated Statements of Operations). SaaS revenue growth remains robust (38% annually, 27% in Q2), now representing 79% of total revenue in Q2 2026 (10-Q 2026-06-30, MD&A Revenue table). The primary headwind is modest gross‑margin erosion, but operating expense growth (17% annually) is well below revenue growth (27%), delivering clear operating leverage.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Six‑month operating cash flow surged to $40.2 million in 2026 from $20.8 million in 2025, driven by higher net income ($42.8 million vs $6.5 million) and favorable working‑capital movements (10-Q 2026-06-30, Consolidated Statements of Cash Flows). Annual operating cash flow was $85.3 million in FY2025, slightly below FY2024’s $88.9 million but up sharply from FY2023’s $34.7 million (10-K 2025-12-31, Consolidated Statements of Cash Flows). Investing cash outflows normalized to $3.4 million in six‑month 2026 (mostly capex and internal‑use software) after a $14.9 million acquisition outflow in the prior-year period (10-Q 2026-06-30, Consolidated Statements of Cash Flows). Financing activities were dominated by share repurchases ($110.3 million in six‑month 2026 vs $19.0 million in six‑month 2025) and warrant exercises that brought in $168.2 million in FY2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The company holds $417.3 million in cash with zero debt as of June 30 2026 (10-Q 2026-06-30, Consolidated Balance Sheets).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Year‑end 2025 total assets grew to $789.2 million from $519.1 million, equity rose to $478.7 million from $270.9 million, and cash increased to $481.1 million from $290.7 million (10-K 2025-12-31, Consolidated Balance Sheets). Deferred revenue (current + non‑current) expanded to $201.0 million from $153.3 million, reflecting contract growth (10-K 2025-12-31, Consolidated Balance Sheets). At June 30 2026, cash stood at $417.3 million, total assets at $757.0 million, and equity at $436.9 million after $110.3 million of share repurchases in the first half (10-Q 2026-06-30, Consolidated Balance Sheets). Liabilities increased modestly to $320.1 million from $310.5 million, primarily from higher deferred revenue and operating‑lease liabilities. No debt is outstanding; the $30 million revolver (plus $20 million accordion) remains undrawn and covenant‑compliant (10-Q 2026-06-30, MD&A Indebtedness). The balance sheet remains highly liquid with no near‑term maturity pressure beyond the revolver’s November 2026 maturity.

6. Data Gaps

• Quarterly income‑statement and cash‑flow data for Q1 2026, Q3 2025, Q4 2025, and Q1 2025 are not fully available in the provided filings (only Q2 2026 and six‑month 2026/2025 are disclosed in the 10‑Q 2026‑06‑30).
• Standalone quarterly cash‑flow statements (three‑month periods) are not provided; only six‑month aggregates appear in the 10‑Q 2026‑06‑30.
• ARR is disclosed only at June 30 2026 and June 30 2025 in the 10‑Q 2026‑06‑30; quarterly ARR for other periods is absent.
• Detailed breakdown of “Other segment items” in the segment note (including mark‑to‑market earn‑out/warrant adjustments) is not quantified for quarterly periods.
• Full 10‑Q filings for 2026‑03‑31, 2025‑09‑30, and 2025‑06‑30 were truncated in the provided materials, limiting quarterly trend analysis to the periods explicitly shown.